Evidence map›Paper›PMID 30795573›Full record

ArticleInternational journal of molecular sciences2019

3D-Printed Bioactive Calcium Silicate/Poly-ε-Caprolactone Bioscaffolds Modified with Biomimetic Extracellular Matrices for Bone Regeneration.

Yuan-Haw Andrew Wu, Yung-Cheng Chiu, Yen-Hong Lin, Chia-Che Ho, Ming-You Shie, Yi-Wen Chen

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. FeSInternational journal of bioprinting · 2023
    Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yuan-Haw Andrew WuSchool of Medicine, China Medical University, Taichung 40447, Taiwan. u102001503@cmu.edu.tw.
Yung-Cheng ChiuSchool of Medicine, China Medical University, Taichung 40447, Taiwan. e0919908626@yahoo.com.tw.
Yen-Hong Lin3D Printing Medical Research Center, China Medical University Hospital, Taichung 40447, Taiwan. roger.lin0204@gmail.com.
Chia-Che Ho3D Printing Medical Research Center, China Medical University Hospital, Taichung 40447, Taiwan. sfox1223@gmail.com.
Ming-You Shie3D Printing Medical Research Center, China Medical University Hospital, Taichung 40447, Taiwan. eric@mail.cmu.edu.tw.ORCID 0000-0002-0650-4344
Yi-Wen ChenGraduate Institute of Biomedical Sciences, China Medical University, Taichung 40447, Taiwan. evinchen@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Currently, clinically available orthopedic implants are extremely biocompatible but they lack specific biological characteristics that allow for further interaction with surrounding tissues. The extracellular matrix (ECM)-coated scaffolds have received considerable interest for bone regeneration due to their ability in upregulating regenerative cellular behaviors. This study delves into the designing and fabrication of three-dimensional (3D)-printed scaffolds that were made out of calcium silicate (CS), polycaprolactone (PCL), and decellularized ECM (dECM) from MG63 cells, generating a promising bone tissue engineering strategy that revolves around the concept of enhancing osteogenesis by creating an osteoinductive microenvironment with osteogenesis-promoting dECM. We cultured MG63 on scaffolds to obtain a dECM-coated CS/PCL scaffold and further studied the biological performance of the dECM hybrid scaffolds. The results indicated that the dECM-coated CS/PCL scaffolds exhibited excellent biocompatibility and effectively enhanced cellular adhesion, proliferation, and differentiation of human Wharton's Jelly mesenchymal stem cells by increasing the expression of osteogenic-related genes. They also presented anti-inflammatory characteristics by showing a decrease in the expression of tumor necrosis factor-alpha (TNF-α) and interleukin-1 (IL-1). Histological analysis of in vivo experiments presented excellent bone regenerative capabilities of the dECM-coated scaffold. Overall, our work presented a promising technique for producing bioscaffolds that can augment bone tissue regeneration in numerous aspects.

Indexed as

Bone RegenerationPrinting, Three-DimensionalAnimalsBiomimetic MaterialsCalcium CompoundsCell AdhesionCell LineCell ProliferationExtracellular MatrixHumansMesenchymal Stem CellsOsteogenesisPolyestersRatsRats, WistarSilicatesCalcium Compoundscalcium silicatepolycaprolactonePolyestersSilicates3D scaffoldcalcium silicatedecellularizedextracellular matrixosteogenesispolycaprolactone

Identifiers

PMID30795573
PMCPMC6413038

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.